These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32003009)

  • 1. New Insights Into Intestinal Failure-Associated Liver Disease in Children.
    Khalaf RT; Sokol RJ
    Hepatology; 2020 Apr; 71(4):1486-1498. PubMed ID: 32003009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management.
    Lee WS; Chew KS; Ng RT; Kasmi KE; Sokol RJ
    Hepatol Int; 2020 May; 14(3):305-316. PubMed ID: 32356227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into intestinal failure-associated liver disease in adults: A comprehensive review of the literature.
    Fousekis FS; Mitselos IV; Christodoulou DK
    Saudi J Gastroenterol; 2021; 27(1):3-12. PubMed ID: 33642350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
    Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current strategies for managing intestinal failure-associated liver disease.
    Secor JD; Yu L; Tsikis S; Fligor S; Puder M; Gura KM
    Expert Opin Drug Saf; 2021 Mar; 20(3):307-320. PubMed ID: 33356650
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric intestinal failure-associated liver disease.
    Courtney CM; Warner BW
    Curr Opin Pediatr; 2017 Jun; 29(3):363-370. PubMed ID: 28333693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 lipids for intestinal failure associated liver disease.
    Diamond IR; Pencharz PB; Wales PW
    Semin Pediatr Surg; 2009 Nov; 18(4):239-45. PubMed ID: 19782305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights.
    Mihajlovic M; Rosseel Z; De Waele E; Vinken M
    Toxicol Sci; 2024 Apr; 199(1):1-11. PubMed ID: 38383052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future.
    Carter BA; Karpen SJ
    Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.
    Lauriti G; Zani A; Aufieri R; Cananzi M; Chiesa PL; Eaton S; Pierro A
    JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):70-85. PubMed ID: 23894170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
    Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
    Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.
    Venick RS; Calkins K
    Curr Opin Organ Transplant; 2011 Jun; 16(3):306-11. PubMed ID: 21505340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention and treatment of intestinal failure-associated liver disease in neonates and children.
    Nehra D; Fallon EM; Puder M
    Surg Clin North Am; 2011 Jun; 91(3):543-63. PubMed ID: 21621695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text].
    Nandivada P; Fell GL; Mitchell PD; Potemkin AK; O'Loughlin AA; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):930-937. PubMed ID: 26962059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal failure-associated liver disease: what do we know today?
    Kelly DA
    Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Insights Regarding Intestinal Failure-Associated Liver Disease (IFALD): A Narrative Review.
    Zafirovska M; Zafirovski A; Rotovnik Kozjek N
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal failure-associated liver disease].
    Fan SX; Wang J; Li Q; Li YS; Guan WX; Li JS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jan; 24(1):94-100. PubMed ID: 33461259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the management of intestinal failure-associated liver disease.
    Wiles A; Woodward JM
    Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):265-72. PubMed ID: 19339882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.